Advantage Alpha Capital Partners’s Castle Biosciences CSTL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$327K	Sell	16,021 -3,784	-19%	-$77.3K	0.09%	108
2025 Q1	$396K	Buy	+19,805	New	+$396K	0.1%	101
2024 Q4	–	Sell	-10,940	Closed	-$312K	–	160
2024 Q3	$312K	Buy	+10,940	New	+$312K	0.07%	157